Recombinant Human CXCL7 Protein，His

CXCL7, also known as platelet factor 4 (PF4), is a chemokine predominantly secreted by activated platelets and plays a significant role in various physiological and pathological processes. Its involvement in inflammation, immune response, and tissue repair makes it a molecule of interest in both basic and clinical research. CXCL7 acts by binding to receptors on the surface of various cell types, influencing cellular migration, activation, and even angiogenesis. Dysregulation of CXCL7 expression has been implicated in several diseases, including atherosclerosis, cancer, and inflammatory disorders. Understanding the functional properties of CXCL7 through recombinant protein studies allows for the exploration of its mechanisms of action and potential therapeutic applications. Additionally, the recombinant CXCL7 protein can be used as a valuable tool for studying its interactions with specific receptors and other signaling pathways. Researchers have focused on developing recombinant CXCL7 to analyze its structural characteristics and biological activities, which can lead to the identification of new drug targets and the development of novel therapeutic strategies. The growing interest in CXCL7 underscores its importance in health and disease, highlighting the necessity for further investigation into its functional roles and potential as a biomarker or therapeutic candidate.